#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar rhabdomyosarcoma Crigler-Najjar syndrome Idiopathic pulmonary fibrosis Glycogen storage disease type II Brain stem glioma Waldenstrom's macroglobulinaemia recurrent Anti-myelin-associated glycoprotein associated polyneuropathy Malignant peritoneal neoplasm Infertility female Optic ischaemic neuropathy Hyperinsulinism Hodgkin's disease recurrent Neurodermatitis Anal cancer recurrent Germ cell cancer More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Trials in Disease Combined immunodeficiency – Basic Information CADASIL – Basic Information Glomerulonephritis membranous – Life with Disease Advanced systemic mastocytosis – Life with Disease Niemann-Pick disease – Life with Disease Mitochondrial myopathy Choroid melanoma – Life with Disease Marfan’s syndrome – Trials in Disease SAPHO syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bulevirtide Neratinib Doxorubicin Doxycycline Hyclate Lacutamab Ganaxolone Clemastine Fumarate Sisunatovir Mosliciguat Remifentanil Hydrochloride Phenylephrine Hydrochloride Tasimelteon Lucerastat Efmoroctocog Alfa Ciclosporin ALE.P02 ZILEBESIRAN Platelet Concentrate Paliperidone Mk-0616 More therapies…

    Learn about Your Condition

    Hyperoxaluria Obsessive-compulsive disorder Hyperthyroidism Spondylolisthesis Retinal artery occlusion Spinal cord injury cervical Systemic lupus erythematosus White matter lesion Porphyria non-acute Neuromuscular scoliosis Anxiety Acute lymphocytic leukaemia Essential hypertension Urinary incontinence Tinnitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Study on Binimetinib, Encorafenib, and Pembrolizumab for Patients with BRAF V600 Mutation-Positive Melanoma and Brain Metastasis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    • Pembrolizumab
    France

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bictegravir
    • Doravirine
    • Islatravir
    France Germany Spain

  • Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8

  • Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium France Germany Hungary Italy Poland +1

  • Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Gadobutrol
    • Glenzocimab
    France

  • Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Baricitinib
    • Fluorescein Sodium
    • Prednisone
    France

  • Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Odronextamab
    France Germany Italy Poland Spain

  • Study on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Hungary Italy Spain

  • Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Rituximab
    • Venetoclax
    Austria Belgium Czechia France Italy Poland +2
Previous Page
1 … 13 14 15 16 17 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!